A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
12/2002
12/05/2002	WO2001098362A3 Chemically-modified antimicrobial peptides, compositions and methods of production and use
12/05/2002	WO2001064949B1 Diagnostics and therapeutics for glaucoma
12/05/2002	WO2001032926A3 Differentially expressed genes involved in angiogenesis, the polypeptides encoded thereby, and methods of using the same
12/05/2002	US20020183507 Novel human GABA receptor proteins and polynucleotides encoding the same
12/05/2002	US20020183503 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of immunological, infectious, inflammatory and cancer disorders
12/05/2002	US20020183399 Method and compositions for treating rosacea
12/05/2002	US20020183391 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives
12/05/2002	US20020183381 Inhibitor for neovasculation, cell multiplication, lumen formation and FGF
12/05/2002	US20020183376 Method of treating ocular inflammatory and angiogenesis-related disorders of the posterior segment of the eye using an amide derivative of flurbiprofen or ketorolac
12/05/2002	US20020183369 For therapy of diabetes, insulin resistance, diabetic neuropathy, diabetic nephropathy, diabetic retinopathy, cataracts, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemia, hyperlipidemia, atherosclerosis
12/05/2002	US20020183368 Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma
12/05/2002	US20020183365 Therapy or ameliorating an indication of the invention in an animal, including a human, comprising administering heteroaryl compond
12/05/2002	US20020183359 Ophthalmic composition
12/05/2002	US20020183328 Method of using (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury
12/05/2002	US20020183326 1,2,4-triazolo[4,3-B]pyrido[3,2-D]pyridazine derivatives and pharmaceutical compositions containing them
12/05/2002	US20020183282 For skin, muscle, ocular or gastric mucosal healing
12/05/2002	US20020183280 For controlled administration of pharmaceutically active agents to patients, wherein formulation is administered as liquids which thicken to form gels upon instillation into the eye
12/05/2002	US20020183271 Administering to the patient a human MDA-7 polypeptide or a nucleic acid expressing the human MDA-7 polypeptide in eukaryotic cells, whereby the MDA-7 polypeptide inhibits angiogenesis in the patient
12/05/2002	US20020183253 Effecting an increase in the amount of an endostatin in ocular tissues of an individual afflicted with ocular neovascularization to an ocular neovascularization inhibiting effective amount
12/05/2002	US20020183242 Peptide antiangiogenic drugs
12/05/2002	US20020182683 Vascular endothelial growth factor 2
12/05/2002	US20020182612 Diagnosing inflammatory defects in humans; obtain nucleotide sequence sample, incubate with probe associated with preferential allele, detect hybridization, hybridization indicates sensitivty to inflammatory defect
12/05/2002	US20020182266 Vitamin C, vitamin E, beta-carotene, zinc and copper, preferably in tablet form
12/05/2002	US20020182265 Lubricious coatings for substrates
12/05/2002	US20020182255 Especially a sustained release composition for the treatment of ocular and periocular infections.
12/05/2002	US20020182213 Method for the treatment of fibrosis
12/05/2002	US20020182212 Compositions and methods for treating hyperimmune response in the eye
12/05/2002	US20020182185 Method for reducing or preventing transplant rejection in the eye and intraocular implants for use therefor
12/05/2002	CA2449199A1 Coenzyme q and eicosapentaenoic acid (epa)
12/05/2002	CA2448637A1 A pharmaceutical combination comprising either (s)-2-ethoxy-3 [4-(2- {4-methane sulfonyl oxyphenyl} ethoxy)phenyl] propanoic acid or 3-{4-[2- (4-tert-butoxy carbonylamino phenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and insulin
12/05/2002	CA2448320A1 Ribozyme based treatment of female reproductive diseases
12/05/2002	CA2448317A1 Method for treating glaucoma v
12/05/2002	CA2448306A1 Method for treating fibrotic diseases or other indications
12/05/2002	CA2448305A1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
12/05/2002	CA2448294A1 Method for treating fibrotic diseases or other indications vi
12/05/2002	CA2448276A1 Method for treating glaucoma vi
12/05/2002	CA2448248A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases
12/05/2002	CA2448148A1 Carbohydrate-associated proteins
12/05/2002	CA2448062A1 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals
12/05/2002	CA2448023A1 Carboxamide-substituted phenylurea derivatives and method for production thereof as medicaments
12/05/2002	CA2447562A1 Pirenzepine ophthalmic gel
12/05/2002	CA2447475A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002	CA2443713A1 Proteins associated with cell growth, differentiation, and death
12/05/2002	CA2443346A1 Anticholinergic compounds and methods of use
12/04/2002	EP1262179A1 Photodynamic therapy for selectively closing neovasa in eyeground tissue
12/04/2002	EP1261712A2 Proteins named fctrx and nucleic acids encoding same
12/04/2002	EP1261644A2 Modulation of the activity of the endothelial cell surface receptor ecrtp/dep-1 in the regulation of angiogenesis
12/04/2002	EP1261636A2 Human protein kinases and protein kinase-like enzymes
12/04/2002	EP1261605A1 Benzoxazole derivatives as tnf and pde iv inhibitors
12/04/2002	EP1261598A1 Internal 1,15-lactones of fluprostenol and related prostaglandin f2alpha analogs and their use in the treatment of glaucoma and intraocular hypertension
12/04/2002	EP1261590A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases
12/04/2002	EP1261585A1 Substituted indole mannich bases
12/04/2002	EP1261378A2 Biodegradable immunomodulatory formulations and methods for use thereof
12/04/2002	EP1261364A1 Method of treating or inhibiting cellular injury or cell death
12/04/2002	EP1261359A2 An improved herbal composition having antiallergic properties and a process for the preparation thereof
12/04/2002	EP1261357A1 Isolation and transplantation of retinal stem cells
12/04/2002	EP1261330A2 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals
12/04/2002	EP1261329A2 Il-8 receptor antagonists
12/04/2002	EP1261317A2 Methods and compositions for treating and preventing posterior segment ophthalmic disorders
12/04/2002	EP1131304B1 N- 4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, an irreversible inhibitor of tyrosine kinases
12/04/2002	EP0928291B1 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase
12/04/2002	CN1095370C Nutritious eye-protecting health powder for middle aged and old people
12/03/2002	US6489367 Semifluorinated alkanes and the use thereof
12/03/2002	US6489333 Heterocyclic compounds containing a guanidine mimic, for inhibition of cell adhesion, treatment of angiogenesis disorders, inflammation, cancer metastasis, diabetic retinopathy, thrombosis, restenosis, macular degeneration
12/03/2002	US6489327 Tryptase inhibitors
12/03/2002	US6489321 Nonpeptide substituted benzothiazepines as vasopressin antagonists
11/2002
11/28/2002	WO2002095704A1 Use of nf-kappa-b inhibitors to treat dry eye disorders
11/28/2002	WO2002095391A1 Methods and formulations for increasing the affinity of a1 adenosine receptor ligands for the a1 adenosine receptor
11/28/2002	WO2002095011A2 Inactivation of genes of the mep pathway
11/28/2002	WO2002095007A2 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002	WO2002094833A1 Novel pyrrole derivatives as pharmaceutical agents
11/28/2002	WO2002094830A2 DIHYDROPYRROLO[1,2-A]INDOLE AND TETRAHYDROPYRIDO[1,2-a]-INDOLE DERIVATIVES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
11/28/2002	WO2002094825A1 Novel spiropiperidine derivative
11/28/2002	WO2002094823A1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
11/28/2002	WO2002094821A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	WO2002094809A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002	WO2002094795A1 4-aminopyrimidine derivatives
11/28/2002	WO2002094754A1 Vitamin d analogues
11/28/2002	WO2002094311A1 Use of proteasome inhibitors to treat dry eye disorders
11/28/2002	WO2002094296A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/28/2002	WO2002094284A1 Method of treating dry eye disorders
11/28/2002	WO2002094263A2 Caspase inhibitors and uses thereof
11/28/2002	WO2002094253A1 Agents for relieving eye controlling function error
11/28/2002	WO2002094202A2 Methods for protecting allogeneic islet transplant using soluble ctla4 mutant molecules
11/28/2002	WO2002094193A1 Methods for inhibiting angiogenesis
11/28/2002	WO2002094192A2 Antibodies against tumor necrosis factor delta (april)
11/28/2002	WO2002094177A2 Novel nucleic acids and their therapeutic use in ophthalmology
11/28/2002	WO2002085897A8 Heterocyclic compounds for aging-related and diabetic vascular complications
11/28/2002	WO2002083712A8 Transporters and ion channels
11/28/2002	WO2002080887A3 Timed pulse release composition
11/28/2002	WO2002079408A3 Short bioactive peptides and methods for their use
11/28/2002	WO2002044153A8 4-6-diphenyl pyridine derivatives as antiinflammatory agents
11/28/2002	WO2002035235A3 Net as regulator of angiogenic expression
11/28/2002	WO2002024924A3 Protein phosphatases
11/28/2002	WO2002020002A3 A method for treating allergies
11/28/2002	WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002	WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002	US20020178135 Image searching system and image searching method, and a recording medium storing an image searching program
11/28/2002	US20020177626 Comprises analgesics such as ibuprofen and diphenhydramine; storage stability
11/28/2002	US20020177620 Prostanoic acid derivatives as agents for lowering intraocular pressure

1 ... 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 ... 531